Effect of combination therapy of angiotensin receptor antagonist with calcium antagonist or with diuretics on left ventricular hypertrohy

Effect of combination therapy of angiotensin receptor antagonist with calcium antagonist or with diuretics on left ventricular hypertrohy - Combination theraphy on LVH

Status

Active, not recruiting

Phases

Unknown

Study type

Interventional

Source

JPRN

Registry ID

JPRN-UMIN000004176

Enrollment

Registered

2010-09-08

Start date

2010-09-01

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

hypertensive cardiac hypertrophy

Interventions

azernidipine added on olmesartan triclormethizide added on olmesartan

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: hypertensive cardiac hypertrophy

Exclusion criteria

Exclusion criteria: No toleracne to the drugs

Design outcomes

Primary

Measure	Time frame
left ventricular mass reduction	—

Countries

Japan

Contacts

Public ContactKeizo Kimura

Wakayama Medical University Division of Cardiovacular Medicine

k0301crm@wakayama-med.ac.jp

Outcome results

None listed

Source: JPRN (via WHO ICTRP) · Data processed: Jul 3, 2026